SCHEMBL3332046

SCHEMBL3332046

CC(C)(C)OC(=O)N1CCC(c2ccc(NS(C)(=O)=O)cc2)=N1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 2/20 0.50
ALDH1A1 P00352 8/20 0.45
KDM4E B2RXH2 7/20 0.45
MAPT P10636 4/20 0.45
GAA P10253 3/20 0.45
KMT2A Q03164 3/20 0.45
HPGD P15428 5/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
RAB9A P51151 2/20 0.44
BCL2 P10415 3/20 0.43
BECN1 Q14457 3/20 0.43
GLA P06280 4/20 0.42
PKM P14618 3/20 0.42
HTT P42858 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
PTPN2 P17706 1/20 0.40
PTPN1 P18031 1/20 0.40
PTPN6 P29350 1/20 0.40
MEN1 O00255 2/20 0.40
POLB P06746 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3356617 0.82 ALDH1A1 (0.50) GPR119ALDH1A1HPGDSMN1; SMN2RAB9A
SCHEMBL3327561 0.81 PTPN2 (0.46) GPR119ALDH1A1HPGDSMN1; SMN2RAB9A
SCHEMBL3324006 0.80 ALDH1A1 (0.49) GPR119ALDH1A1GAAHPGDSMN1; SMN2
SCHEMBL3326866 0.76 ALDH1A1 (0.53) ALDH1A1MAPTKMT2AHPGDSMN1; SMN2
SCHEMBL31110435 0.74 NAMPT (0.62) GPR119PTPN2PTPN1PTPN6
SCHEMBL31110453 0.74 NAMPT (0.62) GPR119PTPN2PTPN1PTPN6
SCHEMBL3328483 0.73 KDM4E (0.46) ALDH1A1KDM4EMAPTGAAKMT2A
SCHEMBL3323489 0.72 MAOB (0.52) ALDH1A1KDM4EMAPTKMT2AHPGD
SCHEMBL3326687 0.71 KDM4E (0.46) ALDH1A1KDM4EMAPTGAAKMT2A
SCHEMBL5600152 0.71 NR1H2 (0.65) GPR119KDM4EMAPTRAB9APTPN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2148865-B1 PYRAZOLE INHIBITORS OF WNT SIGNALING GENENTECH INC (US) 2017-05-17 EP disclosed
US-20100137394-A1 PYRAZOLE INHIBITORS OF WNT SIGNALING GRENENTECH, INC. (US) 2010-06-03 US disclosed
EP-2148865-A1 PYRAZOLE INHIBITORS OF WNT SIGNALING Genentech, Inc. (US) 2010-02-03 EP disclosed
WO-2008137408-A1 PYRAZOLE INHIBITORS OF WNT SIGNALING GENENTECH, INC. (US) 2008-11-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137394-A1 PYRAZOLE INHIBITORS OF WNT SIGNALING WNT1, WNT3A, CTNNB1 GPR119 955/4885ALDH1A1 1479/4885KDM4E 2110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.